Details
Stereochemistry | RACEMIC |
Molecular Formula | C28H40N2O5 |
Molecular Weight | 484.6276 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC(OC)=C1OC)C(CCCN(C)CCC2=CC(OC)=C(OC)C=C2)(C#N)C(C)C
InChI
InChIKey=XQLWNAFCTODIRK-UHFFFAOYSA-N
InChI=1S/C28H40N2O5/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23(31-4)24(16-21)32-5/h10-11,16-18,20H,9,12-15H2,1-8H3
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/7510624
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7510624
Gallopamil is a L-type calcium channel blocker designed for the treatment of coronary heart diseases: angina pectoris, prinzmetal angina and hypertonia.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095229 Sources: http://www.ncbi.nlm.nih.gov/pubmed/7510624 |
5.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | PROCORUM Approved UseUnknown |
|||
Primary | PROCORUM Approved UseUnknown |
|||
Primary | PROCORUM Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
The effect of a calcium antagonist (D600) on isoprenaline-induced myocardial necrosis in the rat. | 1979 Jun |
|
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. | 1984 Sep |
|
Synthesis and release of luteinizing hormone in vitro by rat anterior pituitary cells: effects of gallopamil hydrochloride (D600) and pimozide. | 1985 Oct |
|
A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris. | 1987 |
|
Involvement of ion channels in the induction of proenkephalin A gene expression by nicotine and cAMP in bovine chromaffin cells. | 1987 Mar 25 |
|
Beta-adrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart. | 1990 Dec |
|
Mechanisms involved in the transcriptional activation of proenkephalin gene expression in bovine chromaffin cells. | 1990 Nov 5 |
|
[Drug treatment of myocardial ischemia]. | 1991 |
|
Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs. | 1993 Feb 16 |
|
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4. | 2001 Dec |
|
Initial and sustained phases of myogenic response of rat mesenteric small arteries. | 2001 Nov |
|
Intracellular and extracellular calcium utilization during hypoxic vasoconstriction of cyclostome aortas. | 2001 Nov |
|
On the role of Ca(2+)- and voltage-dependent inactivation in Ca(v)1.2 sensitivity for the phenylalkylamine (-)gallopamil. | 2001 Oct 12 |
|
A large sustained Ca2+ elevation occurs in unstimulated spines during the LTP pairing protocol but does not change synaptic strength. | 2002 |
|
An increase in extracellular Ca(2+) concentration induces pigment aggregation in teleostean melanophores. | 2002 Aug |
|
A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients. | 2002 Aug |
|
Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution. | 2002 Oct 1 |
|
Verapamil drug metabolism studies by automated in-tube solid phase microextraction. | 2002 Sep 5 |
|
Force response to stretches in activated frog muscle fibres at low tension. | 2003 |
|
Demonstration of direct bioanalysis of drugs in plasma using nanoelectrospray infusion from a silicon chip coupled with tandem mass spectrometry. | 2003 Feb 15 |
|
Characteristics of sperm motility induced on the egg-jelly in the internal fertilization of the newt, Cynops pyrrhogaster. | 2003 Mar |
|
A tale of two fibrillations. | 2003 Nov 11 |
|
Role of sarcoplasmic reticulum Ca2+ content in Ca2+ entry of bovine airway smooth muscle cells. | 2003 Oct |
|
[L-type calcium channels involvement in aortic smooth muscle contraction as revealed by membrane potential and active force dynamics]. | 2004 Apr-Jun |
|
Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels. | 2004 Dec 31 |
|
Changes in calcium signalling, gravitropism, and statocyte ultrastructure in pea roots induced by calcium channel blockers. | 2004 Jul |
|
L-type Ca2+ channel antagonists block voltage-dependent Ca2+ channels in identified leech neurons. | 2004 Jul 9 |
|
Non-cross-bridge calcium-dependent stiffness in frog muscle fibers. | 2004 Jun |
|
NMDA receptor-mediated depolarizing after-potentials in the basal dendrites of CA1 pyramidal neurons. | 2004 Mar |
|
Multidimensional on-line sample preparation of verapamil and its metabolites by a molecularly imprinted polymer coupled to liquid chromatography-mass spectrometry. | 2004 Mar 5 |
|
Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones. | 2004 Oct |
|
Mother rotors and the mechanisms of D600-induced type 2 ventricular fibrillation. | 2004 Oct 12 |
|
Pharmacophoric features and Ca2+ ion holding capacity of verapamil. | 2005 Dec 15 |
|
An ionic model for rhythmic activity in small clusters of embryonic chick ventricular cells. | 2005 Jul |
|
Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. | 2005 Jun |
|
Insulin stimulates Ca2+ uptake via PKC, cAMP, and p38 MAPK in mouse embryonic stem cells. | 2005 May 6 |
|
Nitric oxide involvement in pancreatic beta cell apoptosis by glibenclamide. | 2006 Feb |
|
A selective beta2-adrenergic agonist, terbutaline, improves sepsis-induced diaphragmatic dysfunction in the rat. | 2006 Jul 24 |
|
Airway smooth muscle as a target of asthma therapy: history and new directions. | 2006 Sep 29 |
|
Influence of model melanoidins on calcium-dependent transport mechanisms in smooth muscle tissue. | 2007 Apr |
|
Persistent (>24h) long-term depression in the dentate gyrus of freely moving rats is not dependent on activation of NMDA receptors, L-type voltage-gated calcium channels or protein synthesis. | 2007 Jan |
|
Endogenous alkaline transients boost postsynaptic NMDA receptor responses in hippocampal CA1 pyramidal neurons. | 2007 Jul 11 |
|
Effects of phenylalkylamines and benzothiazepines on Ca(v)1.3-mediated Ca2+ currents in neonatal mouse inner hair cells. | 2007 Nov 14 |
|
Formation of DNA-damaging N-nitroso compounds from the interaction of calcium-channel blockers with nitrite. | 2007 Sep 5 |
|
Mechanisms of potassium- and capsaicin-induced axonal calcitonin gene-related peptide release: involvement of L- and T-type calcium channels and TRPV1 but not sodium channels. | 2008 Feb 6 |
|
Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of Na+/H+ and Na+/Ca2+ exchangers. | 2008 May |
|
Ca2+ pathway involved in the refilling of store sites in rat adrenal medullary cells. | 2009 Apr |
|
Structural model for phenylalkylamine binding to L-type calcium channels. | 2009 Oct 9 |
|
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
|
Reduction in extracellular Ca2+ attenuates endothelium-dependent relaxation more than nitroprusside-induced relaxation. | 2010 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6367415
150 mg/day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C08DA02
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
||
|
NCI_THESAURUS |
C333
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
||
|
WHO-VATC |
QC08DA02
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1275
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
1234
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
GALLOPAMIL
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL51149
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
DTXSID5045172
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
16662-47-8
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
56949-78-1
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
SUPERSEDED | |||
|
100000084512
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
DB12923
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
C83725
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
SUB07874MIG
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
4318
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
4648
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | RxNorm | ||
|
D005711
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | |||
|
m5656
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
39WPC8JHR8
Created by
admin on Fri Dec 15 16:52:37 GMT 2023 , Edited by admin on Fri Dec 15 16:52:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)